drugset / Trial / NCT01337245

Emergency Treatment of Coral Snake Envenomation With Antivenom

NCT01337245 ↗

Phase 3 Completed 26 enrolled University of Arizona
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to see whether a new F(ab')2 antivenom will prevent injury and death from the bite of a coral snake. Funding Source - FDA OOPD.

Timeline

Start
2012-05
Primary completion
2016-11-11
Completion
2016-11-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Snake (Micrurus) North American immune F(ab')2 Equine Protein / enzyme biologic — Intravenous